Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,338 | 13,173 | 9,243 | 4,972 | 6,262 |
| TOTAL | $12,715 | $13,271 | $9,492 | $5,182 | $6,533 |
| Non-Current Assets | |||||
| PPE Net | 124 | 49 | 59 | 50 | 54 |
| Other Non-Current Assets | 36 | 14 | 14 | 14 | 14 |
| TOTAL | $161 | $63 | $73 | $64 | $68 |
| Total Assets | $12,875 | $13,334 | $9,565 | $5,246 | $6,601 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 162 | N/A | N/A | 73 | 144 |
| Accounts payable and accrued liabilities | 1,314 | 728 | 1,269 | 188 | 344 |
| Accrued Expenses | 562 | 466 | 390 | 294 | 250 |
| TOTAL | $3,630 | $1,876 | $2,341 | $555 | $738 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,591 | 682 | 682 | N/A | N/A |
| TOTAL | $260 | $284 | $455 | $N/A | $N/A |
| Total Liabilities | $3,890 | $2,160 | $2,796 | $555 | $738 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,252 | 1,252 | 1,065 | 868 | 864 |
| Common Shares | 4 | 4 | 3 | 3 | 3 |
| Retained earnings | -13,278 | -10,779 | -8,525 | -5,963 | -4,427 |
| TOTAL | $8,985 | $11,174 | $6,769 | $4,692 | $5,863 |
| Total Liabilities And Equity | $12,875 | $13,334 | $9,565 | $5,246 | $6,601 |